Worth reading
34Immaterial
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
14282
Rights (Series 15(A): 6,141 rights; Series 15(B): 8,141 rights)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights as stock compensation-type stock options (Series 15(A) performance-based medium-term stock acquisition rights; Series 15(B) performance-based long-term stock acquisition rights)
Intended allottee
Category Directors / Number of Employees 2 / Number of rights allotted Series 15(A): 3,479 rights; Series 15(B): 6,710 rights, Category Executive officers / Number of Employees 1 / Number of rights allotted Series 15(A): 715 rights; Series 15(B): 1,431 rights, Category Senior employees at department-head level / Number of Employees 3 / Number of rights allotted Series 15(A): 1,947 rights
Terms of the stock acquisition rights
Number of Stock Acquisition Rights
Total number issued: Series 15(A): 6,141 rights; Series 15(B): 8,141 rights. Unexercised balance: Not disclosed
Categories and Number of Persons Covered
Category Directors / Number of Employees 2 / Number of rights allotted Series 15(A): 3,479 rights; Series 15(B): 6,710 rights, Category Executive officers / Number of Employees 1 / Number of rights allotted Series 15(A): 715 rights; Series 15(B): 1,431 rights, Category Senior employees at department-head level / Number of Employees 3 / Number of rights allotted Series 15(A): 1,947 rights
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights as stock compensation-type stock options (Series 15(A) performance-based medium-term stock acquisition rights; Series 15(B) performance-based long-term stock acquisition rights) |
| Issue price and disposal price | ¥10,600 per stock acquisition right (¥106 per share) |
| Intended allottee | Category Directors / Number of Employees 2 / Number of rights allotted Series 15(A): 3,479 rights; Series 15(B): 6,710 rights, Category Executive officers / Number of Employees 1 / Number of rights allotted Series 15(A): 715 rights; Series 15(B): 1,431 rights, Category Senior employees at department-head level / Number of Employees 3 / Number of rights allotted Series 15(A): 1,947 rights |
| Number of Stock Acquisition Rights | Total number issued: Series 15(A): 6,141 rights; Series 15(B): 8,141 rights. Unexercised balance: Not disclosed |
| Categories and Number of Persons Covered | Category Directors / Number of Employees 2 / Number of rights allotted Series 15(A): 3,479 rights; Series 15(B): 6,710 rights, Category Executive officers / Number of Employees 1 / Number of rights allotted Series 15(A): 715 rights; Series 15(B): 1,431 rights, Category Senior employees at department-head level / Number of Employees 3 / Number of rights allotted Series 15(A): 1,947 rights |
Items this document does not state (23)
Number of shares to be issued or disposed ofTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The total number of stock acquisition rights, payment amounts, allottees and number of people, and number of rights allocated for the stock compensation-type stock options approved at the Board of Directors meeting held on 17 July 2026 have been finalized.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.